0 23

Cited 2 times in

Cited 0 times in

Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Reply

DC Field Value Language
dc.contributor.authorCho, Byoung C.-
dc.contributor.authorSethi, Seema-
dc.contributor.authorSpira, Alexander I.-
dc.date.accessioned2025-11-17T00:47:20Z-
dc.date.available2025-11-17T00:47:20Z-
dc.date.created2025-07-22-
dc.date.issued2025-02-
dc.identifier.issn0028-4793-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208870-
dc.languageEnglish-
dc.publisherMassachusetts Medical Society-
dc.relation.isPartOfNEW ENGLAND JOURNAL OF MEDICINE-
dc.relation.isPartOfNEW ENGLAND JOURNAL OF MEDICINE-
dc.titleAmivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC Reply-
dc.typeArticle-
dc.contributor.googleauthorCho, Byoung C.-
dc.contributor.googleauthorSethi, Seema-
dc.contributor.googleauthorSpira, Alexander I.-
dc.identifier.doi10.1056/NEJMc2414705-
dc.relation.journalcodeJ02371-
dc.identifier.eissn1533-4406-
dc.identifier.pmid39908440-
dc.identifier.urlhttps://www.nejm.org/doi/10.1056/NEJMc2414705-
dc.contributor.affiliatedAuthorCho, Byoung C.-
dc.identifier.scopusid2-s2.0-85218290926-
dc.identifier.wosid001426034400004-
dc.citation.volume392-
dc.citation.number6-
dc.citation.startPage620-
dc.citation.endPage621-
dc.identifier.bibliographicCitationNEW ENGLAND JOURNAL OF MEDICINE, Vol.392(6) : 620-621, 2025-02-
dc.identifier.rimsid88035-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.type.docTypeLetter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.